Conditions: Pleuropulmonary Blastoma; Sertoli-Leydig Cell Tumor; DICER1 Syndrome; Cystic Nephroma; Wilms Tumor; Pineoblastoma; Renal Sarcoma; Nodular Hyperplasia of Thyroid; Nasal Chondromesenchymal Hamartoma; Ciliary Body Medulloepithelioma; Neuroblastoma; Pituitary Cancer; Embryonal Rhabdomyosarcoma; Ovarian Sarcoma; Gynandroblastoma
Intervention:
Sponsors: Children’s Hospitals and Clinics of Minnesota; Children’s National Research Institute; Washington University School of Medicine; ResourcePath, LLC; Beijing Children’s Hospital; University of Cambridge; Emory University; Dana-Farber Cancer Institute; Phoenix Children’s Hospital; Allina Health System; University of California, San Francisco; M.D. Anderson Cancer Center; University of Texas; Kaiser Permanente
**RECRUITING NOW**
Intervention:
Sponsors: Children’s Hospitals and Clinics of Minnesota; Children’s National Research Institute; Washington University School of Medicine; ResourcePath, LLC; Beijing Children’s Hospital; University of Cambridge; Emory University; Dana-Farber Cancer Institute; Phoenix Children’s Hospital; Allina Health System; University of California, San Francisco; M.D. Anderson Cancer Center; University of Texas; Kaiser Permanente
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
